Industry: Chemical & Material
Published Date: 2025-02-24
Pages: 91 Pages
Report ld: 4219056
Request Sample
Customized Report
Polycaprolactam Market Size(US$)

CAGR 2025-2031
6.3%
Market Size,2031
USD 12,230
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Polycaprolactam market size was US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
The North America Polycaprolactam market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Polycaprolactam include BASF SE, Honeywell, Royal DSM N.V, Lanxess, Clariant Corporation, Unitika, DOMO Chemicals, Firestone Textiles Company, Grupa Azoty, LIBOLON, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Polycaprolactam market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polycaprolactam market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Polycaprolactam in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Polycaprolactam manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polycaprolactam revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Polycaprolactam Product Scope
1.2 Polycaprolactam by Type
1.2.1 Global Polycaprolactam Sales by Type (2020 & 2024 & 2031)
1.2.2 Standard Type
1.2.3 Reinforced Type
1.3 Polycaprolactam by Application
1.3.1 Global Polycaprolactam Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Automotive
1.3.3 Machinery
1.3.4 Electronic Appliances
1.3.5 Chemical Building Materials
1.4 Global Polycaprolactam Market Estimates and Forecasts (2020-2031)
1.4.1 Global Polycaprolactam Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Polycaprolactam Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Polycaprolactam Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Polycaprolactam Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Polycaprolactam Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Polycaprolactam Sales Market Share by Region (2020-2025)
2.2.2 Global Polycaprolactam Revenue Market Share by Region (2020-2025)
2.3 Global Polycaprolactam Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Polycaprolactam Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Polycaprolactam Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Polycaprolactam Market Size and Prospective (2020-2031)
2.4.2 Europe Polycaprolactam Market Size and Prospective (2020-2031)
2.4.3 China Polycaprolactam Market Size and Prospective (2020-2031)
2.4.4 Japan Polycaprolactam Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Polycaprolactam Historic Market Review by Type (2020-2025)
3.1.1 Global Polycaprolactam Sales by Type (2020-2025)
3.1.2 Global Polycaprolactam Revenue by Type (2020-2025)
3.1.3 Global Polycaprolactam Price by Type (2020-2025)
3.2 Global Polycaprolactam Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Polycaprolactam Sales Forecast by Type (2026-2031)
3.2.2 Global Polycaprolactam Revenue Forecast by Type (2026-2031)
3.2.3 Global Polycaprolactam Price Forecast by Type (2026-2031)
3.3 Different Types Polycaprolactam Representative Players
4 Global Market Size by Application
4.1 Global Polycaprolactam Historic Market Review by Application (2020-2025)
4.1.1 Global Polycaprolactam Sales by Application (2020-2025)
4.1.2 Global Polycaprolactam Revenue by Application (2020-2025)
4.1.3 Global Polycaprolactam Price by Application (2020-2025)
4.2 Global Polycaprolactam Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Polycaprolactam Sales Forecast by Application (2026-2031)
4.2.2 Global Polycaprolactam Revenue Forecast by Application (2026-2031)
4.2.3 Global Polycaprolactam Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Polycaprolactam Application
5 Competition Landscape by Players
5.1 Global Polycaprolactam Sales by Players (2020-2025)
5.2 Global Top Polycaprolactam Players by Revenue (2020-2025)
5.3 Global Polycaprolactam Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycaprolactam as of 2024)
5.4 Global Polycaprolactam Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Polycaprolactam, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Polycaprolactam, Product Type & Application
5.7 Global Key Manufacturers of Polycaprolactam, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Polycaprolactam Sales by Company
6.1.1.1 North America Polycaprolactam Sales by Company (2020-2025)
6.1.1.2 North America Polycaprolactam Revenue by Company (2020-2025)
6.1.2 North America Polycaprolactam Sales Breakdown by Type (2020-2025)
6.1.3 North America Polycaprolactam Sales Breakdown by Application (2020-2025)
6.1.4 North America Polycaprolactam Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Polycaprolactam Sales by Company
6.2.1.1 Europe Polycaprolactam Sales by Company (2020-2025)
6.2.1.2 Europe Polycaprolactam Revenue by Company (2020-2025)
6.2.2 Europe Polycaprolactam Sales Breakdown by Type (2020-2025)
6.2.3 Europe Polycaprolactam Sales Breakdown by Application (2020-2025)
6.2.4 Europe Polycaprolactam Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Polycaprolactam Sales by Company
6.3.1.1 China Polycaprolactam Sales by Company (2020-2025)
6.3.1.2 China Polycaprolactam Revenue by Company (2020-2025)
6.3.2 China Polycaprolactam Sales Breakdown by Type (2020-2025)
6.3.3 China Polycaprolactam Sales Breakdown by Application (2020-2025)
6.3.4 China Polycaprolactam Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Polycaprolactam Sales by Company
6.4.1.1 Japan Polycaprolactam Sales by Company (2020-2025)
6.4.1.2 Japan Polycaprolactam Revenue by Company (2020-2025)
6.4.2 Japan Polycaprolactam Sales Breakdown by Type (2020-2025)
6.4.3 Japan Polycaprolactam Sales Breakdown by Application (2020-2025)
6.4.4 Japan Polycaprolactam Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 BASF SE
7.1.1 BASF SE Company Information
7.1.2 BASF SE Business Overview
7.1.3 BASF SE Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.1.4 BASF SE Polycaprolactam Products Offered
7.1.5 BASF SE Recent Development
7.2 Honeywell
7.2.1 Honeywell Company Information
7.2.2 Honeywell Business Overview
7.2.3 Honeywell Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Honeywell Polycaprolactam Products Offered
7.2.5 Honeywell Recent Development
7.3 Royal DSM N.V
7.3.1 Royal DSM N.V Company Information
7.3.2 Royal DSM N.V Business Overview
7.3.3 Royal DSM N.V Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Royal DSM N.V Polycaprolactam Products Offered
7.3.5 Royal DSM N.V Recent Development
7.4 Lanxess
7.4.1 Lanxess Company Information
7.4.2 Lanxess Business Overview
7.4.3 Lanxess Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Lanxess Polycaprolactam Products Offered
7.4.5 Lanxess Recent Development
7.5 Clariant Corporation
7.5.1 Clariant Corporation Company Information
7.5.2 Clariant Corporation Business Overview
7.5.3 Clariant Corporation Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Clariant Corporation Polycaprolactam Products Offered
7.5.5 Clariant Corporation Recent Development
7.6 Unitika
7.6.1 Unitika Company Information
7.6.2 Unitika Business Overview
7.6.3 Unitika Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Unitika Polycaprolactam Products Offered
7.6.5 Unitika Recent Development
7.7 DOMO Chemicals
7.7.1 DOMO Chemicals Company Information
7.7.2 DOMO Chemicals Business Overview
7.7.3 DOMO Chemicals Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.7.4 DOMO Chemicals Polycaprolactam Products Offered
7.7.5 DOMO Chemicals Recent Development
7.8 Firestone Textiles Company
7.8.1 Firestone Textiles Company Company Information
7.8.2 Firestone Textiles Company Business Overview
7.8.3 Firestone Textiles Company Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Firestone Textiles Company Polycaprolactam Products Offered
7.8.5 Firestone Textiles Company Recent Development
7.9 Grupa Azoty
7.9.1 Grupa Azoty Company Information
7.9.2 Grupa Azoty Business Overview
7.9.3 Grupa Azoty Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Grupa Azoty Polycaprolactam Products Offered
7.9.5 Grupa Azoty Recent Development
7.10 LIBOLON
7.10.1 LIBOLON Company Information
7.10.2 LIBOLON Business Overview
7.10.3 LIBOLON Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.10.4 LIBOLON Polycaprolactam Products Offered
7.10.5 LIBOLON Recent Development
7.11 Polymeric Resources Corporation
7.11.1 Polymeric Resources Corporation Company Information
7.11.2 Polymeric Resources Corporation Business Overview
7.11.3 Polymeric Resources Corporation Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Polymeric Resources Corporation Polycaprolactam Products Offered
7.11.5 Polymeric Resources Corporation Recent Development
7.12 UBE
7.12.1 UBE Company Information
7.12.2 UBE Business Overview
7.12.3 UBE Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.12.4 UBE Polycaprolactam Products Offered
7.12.5 UBE Recent Development
7.13 EMS-Grivory
7.13.1 EMS-Grivory Company Information
7.13.2 EMS-Grivory Business Overview
7.13.3 EMS-Grivory Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.13.4 EMS-Grivory Polycaprolactam Products Offered
7.13.5 EMS-Grivory Recent Development
7.14 Shakespeare
7.14.1 Shakespeare Company Information
7.14.2 Shakespeare Business Overview
7.14.3 Shakespeare Polycaprolactam Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Shakespeare Polycaprolactam Products Offered
7.14.5 Shakespeare Recent Development
8 Polycaprolactam Manufacturing Cost Analysis
8.1 Polycaprolactam Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Polycaprolactam
8.4 Polycaprolactam Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Polycaprolactam Distributors List
9.3 Polycaprolactam Customers
10 Polycaprolactam Market Dynamics
10.1 Polycaprolactam Industry Trends
10.2 Polycaprolactam Market Drivers
10.3 Polycaprolactam Market Challenges
10.4 Polycaprolactam Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Polycaprolactam was estimated to be worth US$ 8480 million in 2025 and is projected to reach US$ 12930 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 139
USD 3950.00
(Single User License)
The global Polycaprolactam market was valued at US$ 8480 million in 2025 and is anticipated to reach US$ 12930 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 142
USD 2900.00
(Single User License)
The global Polycaprolactam market is projected to grow from US$ 8025 million in 2024 to US$ 12230 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 166
USD 4900.00
(Single User License)
The global market for Polycaprolactam was estimated to be worth US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 121
USD 3950.00
(Single User License)
The global market for Polycaprolactam was valued at US$ 8025 million in the year 2024 and is projected to reach a revised size of US$ 12230 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-02-24
Pages: 105
USD 2900.00
(Single User License)
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published Date: 2024-01-31
Pages: 103
USD 2900.00
(Single User License)
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published Date: 2024-01-16
Pages: 121
USD 3950.00
(Single User License)
The global market for Polycaprolactam was estimated to be worth US$ 8480 million in 2025 and is projected to reach US$ 12930 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-14
Pages: 139
The global Polycaprolactam market was valued at US$ 8480 million in 2025 and is anticipated to reach US$ 12930 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-04-27
Pages: 142
The global Polycaprolactam market is projected to grow from US$ 8025 million in 2024 to US$ 12230 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 166
The global market for Polycaprolactam was estimated to be worth US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 121
The global market for Polycaprolactam was valued at US$ 8025 million in the year 2024 and is projected to reach a revised size of US$ 12230 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-02-24
Pages: 105
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published: 2024-01-31
Pages: 103
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published: 2024-01-16
Pages: 121
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now